DK3475268T3 - Forbindelser til behandling af lidelser, der er følsomme over for serotoninerg regulering styret af 5-HT1A-receptorerne - Google Patents
Forbindelser til behandling af lidelser, der er følsomme over for serotoninerg regulering styret af 5-HT1A-receptorerne Download PDFInfo
- Publication number
- DK3475268T3 DK3475268T3 DK17734043.7T DK17734043T DK3475268T3 DK 3475268 T3 DK3475268 T3 DK 3475268T3 DK 17734043 T DK17734043 T DK 17734043T DK 3475268 T3 DK3475268 T3 DK 3475268T3
- Authority
- DK
- Denmark
- Prior art keywords
- serotoninergic
- compounds
- treatment
- ht1a receptors
- disorders sensitive
- Prior art date
Links
- 102000017911 HTR1A Human genes 0.000 title 1
- 101150015707 HTR1A gene Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000035475 disorder Diseases 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 230000002295 serotoninergic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/38—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16305769.8A EP3260452A1 (en) | 2016-06-24 | 2016-06-24 | Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-ht1a receptors |
| PCT/EP2017/065585 WO2017220799A1 (en) | 2016-06-24 | 2017-06-23 | Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-ht1a receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3475268T3 true DK3475268T3 (da) | 2020-10-26 |
Family
ID=56404042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17734043.7T DK3475268T3 (da) | 2016-06-24 | 2017-06-23 | Forbindelser til behandling af lidelser, der er følsomme over for serotoninerg regulering styret af 5-HT1A-receptorerne |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10562853B2 (enExample) |
| EP (2) | EP3260452A1 (enExample) |
| JP (1) | JP6935873B2 (enExample) |
| CN (1) | CN109563073B (enExample) |
| AU (1) | AU2017281742B2 (enExample) |
| CA (1) | CA3028036A1 (enExample) |
| DK (1) | DK3475268T3 (enExample) |
| ES (1) | ES2831853T3 (enExample) |
| WO (1) | WO2017220799A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119874616B (zh) * | 2025-03-28 | 2025-05-30 | 四川美域高生物医药科技有限公司 | 一种有机中间体及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2702211B1 (fr) * | 1993-03-04 | 1995-06-02 | Pf Medicament | Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique. |
| FR2755967B1 (fr) | 1996-11-21 | 1999-01-29 | Pf Medicament | Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments |
| FR2784378B1 (fr) * | 1998-10-09 | 2000-12-29 | Pf Medicament | Nouveaux derives d'aryl-(4-fluoro-4-[(2-pyridin-2-yl- ethylamino)-methyl]-piperidin-1-yl)-methanone, leur procede de preparation et leur utilisation a titre de medicaments |
| EP2058306A1 (en) * | 2007-11-08 | 2009-05-13 | Schwarz Pharma Ag | Heteroaryl-substituted 2-pyridinyl-methylamine derivatives |
| PL395470A1 (pl) * | 2011-06-29 | 2013-01-07 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Sulfonamidowe pochodne amin alicyklicznych do leczenia chorób osrodkowego ukladu nerwowego |
-
2016
- 2016-06-24 EP EP16305769.8A patent/EP3260452A1/en not_active Withdrawn
-
2017
- 2017-06-23 CA CA3028036A patent/CA3028036A1/en active Pending
- 2017-06-23 US US16/312,847 patent/US10562853B2/en active Active
- 2017-06-23 AU AU2017281742A patent/AU2017281742B2/en active Active
- 2017-06-23 JP JP2019520488A patent/JP6935873B2/ja active Active
- 2017-06-23 EP EP17734043.7A patent/EP3475268B9/en active Active
- 2017-06-23 ES ES17734043T patent/ES2831853T3/es active Active
- 2017-06-23 CN CN201780038390.3A patent/CN109563073B/zh active Active
- 2017-06-23 DK DK17734043.7T patent/DK3475268T3/da active
- 2017-06-23 WO PCT/EP2017/065585 patent/WO2017220799A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP6935873B2 (ja) | 2021-09-15 |
| WO2017220799A1 (en) | 2017-12-28 |
| EP3475268B1 (en) | 2020-08-19 |
| ES2831853T3 (es) | 2021-06-09 |
| EP3475268A1 (en) | 2019-05-01 |
| CA3028036A1 (en) | 2017-12-28 |
| JP2019519615A (ja) | 2019-07-11 |
| CN109563073A (zh) | 2019-04-02 |
| AU2017281742A1 (en) | 2019-01-03 |
| CN109563073B (zh) | 2021-12-07 |
| US20190194132A1 (en) | 2019-06-27 |
| AU2017281742B2 (en) | 2021-01-07 |
| EP3475268B9 (en) | 2021-04-21 |
| US10562853B2 (en) | 2020-02-18 |
| EP3260452A1 (en) | 2017-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286923A (en) | G protein-coupled receptor (gpcr) modulation by imipridones | |
| DK3743070T3 (da) | Forbindelser til behandling af kinaseafhængige lidelser | |
| MA46188A (fr) | Composés indole substitués par pyridyle | |
| DK3119397T3 (da) | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser | |
| DK3242666T3 (da) | Forbindelsee til anvendelse i behandling af tilstande, der er forbundet med SIP1-receptoren | |
| DK3498278T3 (da) | Forbindelser til behandling af sygdomme relateret til DUX4-ekspression | |
| DK3936130T3 (da) | Doseringsskema for Valbenazin til behandling af hyperkinetiske bevægelsesforstyrrelser | |
| MA40774A (fr) | Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38 | |
| DK3481838T3 (da) | Nye fremgangsmåder til fremstillingen af oligonukleotider | |
| DK3503890T3 (da) | Anvendelse af pridopidin til behandling af dystonier | |
| MX393838B (es) | Uso de compuestos heterociclicos para controlar nematodos. | |
| DK3157534T3 (da) | Acetylcholinesterasehæmmere til behandling af dermatologiske tilstande | |
| DK3130592T3 (da) | ANALOGER AF 4H-PYRAZOLO[1,5-á]BENZIMIDAZOL-FORBINDELSER SOM PARPINHIBITORER | |
| DK3665173T3 (da) | Ny fremgangsmåde til yntetisering af amanitiner | |
| DK3390407T3 (da) | Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser | |
| DK3233813T3 (da) | Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser | |
| DK3279202T3 (da) | Krystal af 3,5-disubstitueret benzenalkynylforbindelse | |
| DK3692039T3 (da) | Enantiomerer af substituerede thiazoler som antivirale forbindelser | |
| DK3724173T3 (da) | Forbindelser til behandling af neuromuskulære lidelser | |
| DK3642210T3 (da) | Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser | |
| DK3624795T3 (da) | Kondenserede, heteroaromatiske anilinforbindelser til behandling af hudforstyrrelser | |
| DK3191513T3 (da) | Anvendelse af reslizumab til behandling af moderat til svær eosinofil astma | |
| DK3573620T3 (da) | Sammensætninger til behandling af hypertension | |
| DK3515455T3 (da) | Forbindelser til behandling af lidelser i lipoproteinmetabolismen | |
| DK3256466T3 (da) | 1-heterocyclyl-isochromanylforbindelser og analoger til behandling af cns-forstyrrelser |